Wilding P J, Tattersfield A E
Division of Respiratory Medicine, City Hospital, Nottingham, UK.
Monaldi Arch Chest Dis. 1996 Feb;51(1):39-41.
It is often assumed that there is synergy between corticosteroids and beta-agonists, the two drugs most commonly used to treat asthma. A review of clinical studies of the effect of corticosteroids on the response to a beta-agonist finds no evidence to support this assumption except in subjects taking high doses of beta-agonists and with diminished responsiveness to a beta-agonist. There is some evidence that regular beta-agonist therapy may cause a temporary reduction in the efficacy of corticosteroids in asthma, an effect that is seen when the response to the beta-agonist has worn off. Further studies of this effect are required in view of the very widespread concomitant use of the two drugs.
人们常常认为,治疗哮喘最常用的两种药物——皮质类固醇和β受体激动剂之间存在协同作用。一项关于皮质类固醇对β受体激动剂反应影响的临床研究综述发现,没有证据支持这一假设,除非是在服用高剂量β受体激动剂且对β受体激动剂反应性降低的受试者中。有一些证据表明,常规的β受体激动剂治疗可能会导致皮质类固醇在哮喘治疗中的疗效暂时降低,这种效应在对β受体激动剂的反应消失后可见。鉴于这两种药物的广泛联合使用,需要对这种效应进行进一步研究。